The use of SPEctroscopy during Endoscopy for Detection of PANcreatic Cancer
Completed
- Conditions
- pancreatic cancer
- Registration Number
- NL-OMON28590
- Lead Sponsor
- eiden University Medical Center (LUMC)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 45
Inclusion Criteria
Patients scheduled for EUS-FNA, due to a suspect lesion of the pancreas
-Patients with a minimum age of 18 years
Exclusion Criteria
-Patients who object to participate in this study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The ability of SFR spectroscopy incorporated in EUS-FNA procedure in distinguishing benign and malignant pancreatic tissue by measuring wavelength dependent optical characteristics over a broad wavelength range (400-1000 nm).
- Secondary Outcome Measures
Name Time Method Selection of wavelengths specific for pancreatic tumor detection and evaluation of its diagnostic accuracy compared to cytological diagnosis.